Onchilles Pharma Appoints Dr. Lev Becker As Chief Scientific Officer and Emily Roberts Thomson As Senior Vice President of Development Operations
Onchilles Pharma Appoints Dr. Lev Becker As Chief Scientific Officer and Emily Roberts Thomson As Senior Vice President of Development Operations
01/13/25, 2:23 PM
Location
san diegoIndustry
biotechnology
Position
vice president
chief scientific officer
Onchilles Pharma has announced the appointment of Dr. Lev Becker as Chief Scientific Officer and Emily Roberts-Thomson as Senior Vice President of Development Operations. Dr Becker led the groundbreaking discovery of the ELANE pathway and will focus on advancing the company’s pipeline, while Emily Roberts-Thomson brings over 23 years of global clinical development and operational expertise to the team.
Company Info
Location
san diego, california, united states
Additional Info
Onchilles Pharma was founded on breakthrough research of a novel neutrophil pathway that when activated selectively and comprehensively kills cancer cells. Based on this research, the private biotech company is developing a pipeline of first-in-class drug candidates that have the potential to be broadly effective against a wide range of cancers. Onchilles is headquartered at the Alexandria GradLabs in San Diego.